Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) Peptide
LGALS9
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits Galectin 9 (LGALS9)
- Galectin 9 (LGALS9) (Lectin, Galactoside-Binding, Soluble, 9 (LGALS9))
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-LGALS9 antibody (Catalog #: ARP54821_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- Galectin 9 (LGALS9) (Lectin, Galactoside-Binding, Soluble, 9 (LGALS9))
- Synonymes
- huat Peptide, lgals9a Peptide, ecalectin Peptide, galectin-9 Peptide, Lgals9 Peptide, wu:fd20c09 Peptide, zgc:111833 Peptide, LGALS9 Peptide, AA407335 Peptide, AI194909 Peptide, AI265545 Peptide, LGALS35 Peptide, Lgals5 Peptide, gal-9 Peptide, HUAT Peptide, LGALS9A Peptide, UAT Peptide, UATP.I Peptide, galectin 9 L homeolog Peptide, galectin 9 Peptide, lectin, galactoside-binding, soluble, 9 (galectin 9)-like 3 Peptide, lectin, galactose binding, soluble 9 Peptide, lgals9.L Peptide, lgals9 Peptide, lgals9l3 Peptide, LGALS9 Peptide, Lgals9 Peptide
- Sujet
-
The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. LGALS9 is an S-type lectin. It is overexpressed in Hodgkin's disease tissue and might participate in the interaction between the H&RS cells with their surrounding cells and might thus play a role in the pathogenesis of this disease and/or its associated immunodeficiency.The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. The protein encoded by this gene is an S-type lectin. This galectin is strongly overexpressed in Hodgkin's disease tissue and it might participate in the interaction between the H&RS cells with their surrounding cells and might thus play a role in the pathogenesis of this disease and/or its consistently associated immunodeficiency. The protein has N- and C- terminal carbohydrate-binding domains connected by a link peptide. Multiple alternatively spliced transcript variants have been found for this gene.
Alias Symbols: ECALECTIN, HUAT, MGC117375, MGC125973, MGC125974, galectin-9, LGALS9A
Protein Interaction Partner: CTNNB1,JUP,SLC1A5
Protein Size: 355 - Poids moléculaire
- 39 kDa
- ID gène
- 3965
- NCBI Accession
- NM_009587, NP_033665
- UniProt
- O00182
-
Vous êtes ici:
